Balmot Tablet 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or breaking it. This medicine may be taken with or without food. No dosage adjustment is necessary in patients with renal impairment or older adults. Since there are no data on administration of this medicine to patients with hepatic impairment, the recommended dose in these patients has not been established.

This medication can be absorbed through the skin, therefore women who are pregnant or may become pregnant should not handle or touch this medication directly. Care should be taken to avoid touching broken or crushed pieces of tablets, and children should not be allowed to touch broken pieces of this medication. Women, children under 18, and individuals allergic to this medication or similar components should not take this medication. Patients with genetic problems related to lactose should not use this medication. Adult men planning to conceive should use this medication with caution after consulting a physician as it may affect reproductive capacity. Patients having issues with urinary output or poor liver function need to be especially careful when taking this medication, and it should be administered with caution to patients with liver dysfunction. Patients taking strong CYP3A4 enzyme inhibitors for a long time may find an increase in the blood concentration of this medication, necessitating caution. During the use of this medication, side effects related to sexual function such as erectile dysfunction, reduced libido, and ejaculatory disorders may occur, and these symptoms may persist even after discontinuation of the medication. Additionally, side effects such as gynecomastia, headaches, gastrointestinal discomfort, and dizziness have also been reported. Long-term use necessitates regular screening for prostate cancer risk and periodic checks of prostate-specific antigen (PSA) levels. This medication prevents blood donation to avoid its transmission to pregnant women, thus blood donation should be avoided for at least 6 months after the last dose. Although this medication is known not to affect the ability to drive or operate machinery, symptoms like dizziness may occur rarely, thus caution is needed. In case of overdose, there is no specific antidote, so if symptoms are suspected, immediate consultation with healthcare professionals and appropriate treatment is necessary. This medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration in quality.

• erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the medication's efficacy and prevent degradation.

Appearance

Pale yellow round film-coated tablets

Package unit

30 tablets/box [30 tablets (10 tablets/PTPX3)]